nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.125	0.189	CbGbCtD
Dolasetron—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0951	0.144	CbGbCtD
Dolasetron—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0816	0.123	CbGbCtD
Dolasetron—CYP3A4—Betamethasone—ankylosing spondylitis	0.0816	0.123	CbGbCtD
Dolasetron—CYP3A4—Prednisolone—ankylosing spondylitis	0.0805	0.122	CbGbCtD
Dolasetron—CYP3A4—Prednisone—ankylosing spondylitis	0.076	0.115	CbGbCtD
Dolasetron—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0746	0.113	CbGbCtD
Dolasetron—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0474	0.0717	CbGbCtD
Dolasetron—Convulsion—Prednisolone—ankylosing spondylitis	0.000975	0.00289	CcSEcCtD
Dolasetron—Hypertension—Prednisolone—ankylosing spondylitis	0.000972	0.00288	CcSEcCtD
Dolasetron—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000964	0.00285	CcSEcCtD
Dolasetron—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000964	0.00285	CcSEcCtD
Dolasetron—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000962	0.00285	CcSEcCtD
Dolasetron—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00096	0.00284	CcSEcCtD
Dolasetron—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000958	0.00284	CcSEcCtD
Dolasetron—Bradycardia—Prednisone—ankylosing spondylitis	0.000957	0.00283	CcSEcCtD
Dolasetron—Discomfort—Prednisolone—ankylosing spondylitis	0.000947	0.0028	CcSEcCtD
Dolasetron—Angioedema—Triamcinolone—ankylosing spondylitis	0.000946	0.0028	CcSEcCtD
Dolasetron—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000944	0.00279	CcSEcCtD
Dolasetron—Malaise—Triamcinolone—ankylosing spondylitis	0.000933	0.00276	CcSEcCtD
Dolasetron—Malaise—Methylprednisolone—ankylosing spondylitis	0.000931	0.00276	CcSEcCtD
Dolasetron—Vertigo—Triamcinolone—ankylosing spondylitis	0.00093	0.00275	CcSEcCtD
Dolasetron—Syncope—Triamcinolone—ankylosing spondylitis	0.000928	0.00275	CcSEcCtD
Dolasetron—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000928	0.00275	CcSEcCtD
Dolasetron—Syncope—Methylprednisolone—ankylosing spondylitis	0.000926	0.00274	CcSEcCtD
Dolasetron—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000919	0.00272	CcSEcCtD
Dolasetron—Oedema—Prednisolone—ankylosing spondylitis	0.000919	0.00272	CcSEcCtD
Dolasetron—Dysuria—Methotrexate—ankylosing spondylitis	0.000917	0.00271	CcSEcCtD
Dolasetron—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00091	0.00269	CcSEcCtD
Dolasetron—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000908	0.00269	CcSEcCtD
Dolasetron—Shock—Prednisolone—ankylosing spondylitis	0.000904	0.00267	CcSEcCtD
Dolasetron—Cough—Triamcinolone—ankylosing spondylitis	0.000903	0.00267	CcSEcCtD
Dolasetron—Convulsion—Triamcinolone—ankylosing spondylitis	0.000897	0.00265	CcSEcCtD
Dolasetron—Tachycardia—Prednisolone—ankylosing spondylitis	0.000897	0.00265	CcSEcCtD
Dolasetron—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000895	0.00265	CcSEcCtD
Dolasetron—Hypertension—Triamcinolone—ankylosing spondylitis	0.000894	0.00264	CcSEcCtD
Dolasetron—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000892	0.00264	CcSEcCtD
Dolasetron—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000888	0.00263	CcSEcCtD
Dolasetron—Myalgia—Triamcinolone—ankylosing spondylitis	0.000881	0.00261	CcSEcCtD
Dolasetron—Pneumonia—Methotrexate—ankylosing spondylitis	0.00088	0.0026	CcSEcCtD
Dolasetron—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000879	0.0026	CcSEcCtD
Dolasetron—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000879	0.0026	CcSEcCtD
Dolasetron—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000876	0.00259	CcSEcCtD
Dolasetron—Drowsiness—Methotrexate—ankylosing spondylitis	0.000875	0.00259	CcSEcCtD
Dolasetron—Flushing—Prednisone—ankylosing spondylitis	0.000872	0.00258	CcSEcCtD
Dolasetron—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000871	0.00258	CcSEcCtD
Dolasetron—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000871	0.00258	CcSEcCtD
Dolasetron—Discomfort—Triamcinolone—ankylosing spondylitis	0.000871	0.00258	CcSEcCtD
Dolasetron—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000869	0.00257	CcSEcCtD
Dolasetron—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000862	0.00255	CcSEcCtD
Dolasetron—Angioedema—Dexamethasone—ankylosing spondylitis	0.000858	0.00254	CcSEcCtD
Dolasetron—Angioedema—Betamethasone—ankylosing spondylitis	0.000858	0.00254	CcSEcCtD
Dolasetron—Stomatitis—Methotrexate—ankylosing spondylitis	0.000853	0.00252	CcSEcCtD
Dolasetron—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00085	0.00251	CcSEcCtD
Dolasetron—Malaise—Dexamethasone—ankylosing spondylitis	0.000847	0.00251	CcSEcCtD
Dolasetron—Malaise—Betamethasone—ankylosing spondylitis	0.000847	0.00251	CcSEcCtD
Dolasetron—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000845	0.0025	CcSEcCtD
Dolasetron—Oedema—Triamcinolone—ankylosing spondylitis	0.000845	0.0025	CcSEcCtD
Dolasetron—Vertigo—Betamethasone—ankylosing spondylitis	0.000844	0.0025	CcSEcCtD
Dolasetron—Vertigo—Dexamethasone—ankylosing spondylitis	0.000844	0.0025	CcSEcCtD
Dolasetron—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000843	0.00249	CcSEcCtD
Dolasetron—Syncope—Betamethasone—ankylosing spondylitis	0.000842	0.00249	CcSEcCtD
Dolasetron—Syncope—Dexamethasone—ankylosing spondylitis	0.000842	0.00249	CcSEcCtD
Dolasetron—Arrhythmia—Prednisone—ankylosing spondylitis	0.000839	0.00248	CcSEcCtD
Dolasetron—Haematuria—Methotrexate—ankylosing spondylitis	0.000834	0.00247	CcSEcCtD
Dolasetron—Shock—Triamcinolone—ankylosing spondylitis	0.000831	0.00246	CcSEcCtD
Dolasetron—Shock—Methylprednisolone—ankylosing spondylitis	0.000829	0.00245	CcSEcCtD
Dolasetron—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000825	0.00244	CcSEcCtD
Dolasetron—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000825	0.00244	CcSEcCtD
Dolasetron—Epistaxis—Methotrexate—ankylosing spondylitis	0.000825	0.00244	CcSEcCtD
Dolasetron—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000825	0.00244	CcSEcCtD
Dolasetron—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000825	0.00244	CcSEcCtD
Dolasetron—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000823	0.00243	CcSEcCtD
Dolasetron—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000817	0.00242	CcSEcCtD
Dolasetron—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000815	0.00241	CcSEcCtD
Dolasetron—Convulsion—Betamethasone—ankylosing spondylitis	0.000814	0.00241	CcSEcCtD
Dolasetron—Convulsion—Dexamethasone—ankylosing spondylitis	0.000814	0.00241	CcSEcCtD
Dolasetron—Hypertension—Dexamethasone—ankylosing spondylitis	0.000811	0.0024	CcSEcCtD
Dolasetron—Hypertension—Betamethasone—ankylosing spondylitis	0.000811	0.0024	CcSEcCtD
Dolasetron—Myalgia—Betamethasone—ankylosing spondylitis	0.0008	0.00237	CcSEcCtD
Dolasetron—Myalgia—Dexamethasone—ankylosing spondylitis	0.0008	0.00237	CcSEcCtD
Dolasetron—Anxiety—Betamethasone—ankylosing spondylitis	0.000797	0.00236	CcSEcCtD
Dolasetron—Anxiety—Dexamethasone—ankylosing spondylitis	0.000797	0.00236	CcSEcCtD
Dolasetron—Discomfort—Betamethasone—ankylosing spondylitis	0.00079	0.00234	CcSEcCtD
Dolasetron—Discomfort—Dexamethasone—ankylosing spondylitis	0.00079	0.00234	CcSEcCtD
Dolasetron—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000788	0.00233	CcSEcCtD
Dolasetron—Pain—Prednisolone—ankylosing spondylitis	0.000786	0.00232	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00077	0.00228	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000768	0.00227	CcSEcCtD
Dolasetron—Oedema—Betamethasone—ankylosing spondylitis	0.000767	0.00227	CcSEcCtD
Dolasetron—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000767	0.00227	CcSEcCtD
Dolasetron—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000767	0.00227	CcSEcCtD
Dolasetron—Oedema—Dexamethasone—ankylosing spondylitis	0.000767	0.00227	CcSEcCtD
Dolasetron—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000759	0.00225	CcSEcCtD
Dolasetron—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000759	0.00224	CcSEcCtD
Dolasetron—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000757	0.00224	CcSEcCtD
Dolasetron—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000757	0.00224	CcSEcCtD
Dolasetron—Visual impairment—Methotrexate—ankylosing spondylitis	0.000757	0.00224	CcSEcCtD
Dolasetron—Anaemia—Prednisone—ankylosing spondylitis	0.000756	0.00224	CcSEcCtD
Dolasetron—Shock—Betamethasone—ankylosing spondylitis	0.000754	0.00223	CcSEcCtD
Dolasetron—Shock—Dexamethasone—ankylosing spondylitis	0.000754	0.00223	CcSEcCtD
Dolasetron—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000753	0.00223	CcSEcCtD
Dolasetron—Agitation—Prednisone—ankylosing spondylitis	0.000752	0.00222	CcSEcCtD
Dolasetron—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000751	0.00222	CcSEcCtD
Dolasetron—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000751	0.00222	CcSEcCtD
Dolasetron—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000748	0.00221	CcSEcCtD
Dolasetron—Tachycardia—Betamethasone—ankylosing spondylitis	0.000748	0.00221	CcSEcCtD
Dolasetron—Angioedema—Prednisone—ankylosing spondylitis	0.000747	0.00221	CcSEcCtD
Dolasetron—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000744	0.0022	CcSEcCtD
Dolasetron—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000742	0.0022	CcSEcCtD
Dolasetron—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000741	0.00219	CcSEcCtD
Dolasetron—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000741	0.00219	CcSEcCtD
Dolasetron—Malaise—Prednisone—ankylosing spondylitis	0.000738	0.00218	CcSEcCtD
Dolasetron—Vertigo—Prednisone—ankylosing spondylitis	0.000735	0.00217	CcSEcCtD
Dolasetron—Syncope—Prednisone—ankylosing spondylitis	0.000734	0.00217	CcSEcCtD
Dolasetron—Tinnitus—Methotrexate—ankylosing spondylitis	0.000732	0.00217	CcSEcCtD
Dolasetron—Anorexia—Betamethasone—ankylosing spondylitis	0.000731	0.00216	CcSEcCtD
Dolasetron—Anorexia—Dexamethasone—ankylosing spondylitis	0.000731	0.00216	CcSEcCtD
Dolasetron—Urticaria—Prednisolone—ankylosing spondylitis	0.00073	0.00216	CcSEcCtD
Dolasetron—Fatigue—Triamcinolone—ankylosing spondylitis	0.000728	0.00215	CcSEcCtD
Dolasetron—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000727	0.00215	CcSEcCtD
Dolasetron—Pain—Triamcinolone—ankylosing spondylitis	0.000722	0.00214	CcSEcCtD
Dolasetron—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000719	0.00213	CcSEcCtD
Dolasetron—Hypotension—Betamethasone—ankylosing spondylitis	0.000716	0.00212	CcSEcCtD
Dolasetron—Hypotension—Dexamethasone—ankylosing spondylitis	0.000716	0.00212	CcSEcCtD
Dolasetron—Convulsion—Prednisone—ankylosing spondylitis	0.000709	0.0021	CcSEcCtD
Dolasetron—Hypertension—Prednisone—ankylosing spondylitis	0.000706	0.00209	CcSEcCtD
Dolasetron—Chills—Methotrexate—ankylosing spondylitis	0.000705	0.00208	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000698	0.00207	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000698	0.00207	CcSEcCtD
Dolasetron—Arthralgia—Prednisone—ankylosing spondylitis	0.000696	0.00206	CcSEcCtD
Dolasetron—Myalgia—Prednisone—ankylosing spondylitis	0.000696	0.00206	CcSEcCtD
Dolasetron—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000696	0.00206	CcSEcCtD
Dolasetron—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000695	0.00206	CcSEcCtD
Dolasetron—Anxiety—Prednisone—ankylosing spondylitis	0.000694	0.00205	CcSEcCtD
Dolasetron—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000689	0.00204	CcSEcCtD
Dolasetron—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000688	0.00204	CcSEcCtD
Dolasetron—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000688	0.00204	CcSEcCtD
Dolasetron—Discomfort—Prednisone—ankylosing spondylitis	0.000688	0.00204	CcSEcCtD
Dolasetron—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000677	0.002	CcSEcCtD
Dolasetron—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000675	0.002	CcSEcCtD
Dolasetron—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000675	0.002	CcSEcCtD
Dolasetron—Urticaria—Triamcinolone—ankylosing spondylitis	0.000671	0.00199	CcSEcCtD
Dolasetron—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00067	0.00198	CcSEcCtD
Dolasetron—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000669	0.00198	CcSEcCtD
Dolasetron—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000668	0.00198	CcSEcCtD
Dolasetron—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000668	0.00197	CcSEcCtD
Dolasetron—Oedema—Prednisone—ankylosing spondylitis	0.000668	0.00197	CcSEcCtD
Dolasetron—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000666	0.00197	CcSEcCtD
Dolasetron—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000666	0.00197	CcSEcCtD
Dolasetron—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000666	0.00197	CcSEcCtD
Dolasetron—Fatigue—Dexamethasone—ankylosing spondylitis	0.000661	0.00196	CcSEcCtD
Dolasetron—Fatigue—Betamethasone—ankylosing spondylitis	0.000661	0.00196	CcSEcCtD
Dolasetron—Shock—Prednisone—ankylosing spondylitis	0.000657	0.00194	CcSEcCtD
Dolasetron—Pain—Dexamethasone—ankylosing spondylitis	0.000655	0.00194	CcSEcCtD
Dolasetron—Pain—Betamethasone—ankylosing spondylitis	0.000655	0.00194	CcSEcCtD
Dolasetron—Tachycardia—Prednisone—ankylosing spondylitis	0.000652	0.00193	CcSEcCtD
Dolasetron—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000645	0.00191	CcSEcCtD
Dolasetron—Anorexia—Prednisone—ankylosing spondylitis	0.000636	0.00188	CcSEcCtD
Dolasetron—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000634	0.00188	CcSEcCtD
Dolasetron—Anaemia—Methotrexate—ankylosing spondylitis	0.000632	0.00187	CcSEcCtD
Dolasetron—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000632	0.00187	CcSEcCtD
Dolasetron—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000632	0.00187	CcSEcCtD
Dolasetron—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000627	0.00185	CcSEcCtD
Dolasetron—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000627	0.00185	CcSEcCtD
Dolasetron—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000622	0.00184	CcSEcCtD
Dolasetron—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000621	0.00184	CcSEcCtD
Dolasetron—Malaise—Methotrexate—ankylosing spondylitis	0.000616	0.00182	CcSEcCtD
Dolasetron—Vertigo—Methotrexate—ankylosing spondylitis	0.000614	0.00182	CcSEcCtD
Dolasetron—Urticaria—Dexamethasone—ankylosing spondylitis	0.000609	0.0018	CcSEcCtD
Dolasetron—Urticaria—Betamethasone—ankylosing spondylitis	0.000609	0.0018	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000608	0.0018	CcSEcCtD
Dolasetron—Dizziness—Prednisolone—ankylosing spondylitis	0.000607	0.0018	CcSEcCtD
Dolasetron—Asthenia—Triamcinolone—ankylosing spondylitis	0.000606	0.00179	CcSEcCtD
Dolasetron—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000606	0.00179	CcSEcCtD
Dolasetron—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000606	0.00179	CcSEcCtD
Dolasetron—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000606	0.00179	CcSEcCtD
Dolasetron—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000606	0.00179	CcSEcCtD
Dolasetron—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000605	0.00179	CcSEcCtD
Dolasetron—Paraesthesia—Prednisone—ankylosing spondylitis	0.000599	0.00177	CcSEcCtD
Dolasetron—Pruritus—Triamcinolone—ankylosing spondylitis	0.000598	0.00177	CcSEcCtD
Dolasetron—Cough—Methotrexate—ankylosing spondylitis	0.000597	0.00176	CcSEcCtD
Dolasetron—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000596	0.00176	CcSEcCtD
Dolasetron—Convulsion—Methotrexate—ankylosing spondylitis	0.000592	0.00175	CcSEcCtD
Dolasetron—Dyspepsia—Prednisone—ankylosing spondylitis	0.000588	0.00174	CcSEcCtD
Dolasetron—Myalgia—Methotrexate—ankylosing spondylitis	0.000582	0.00172	CcSEcCtD
Dolasetron—Arthralgia—Methotrexate—ankylosing spondylitis	0.000582	0.00172	CcSEcCtD
Dolasetron—Chest pain—Methotrexate—ankylosing spondylitis	0.000582	0.00172	CcSEcCtD
Dolasetron—Decreased appetite—Prednisone—ankylosing spondylitis	0.00058	0.00172	CcSEcCtD
Dolasetron—Rash—Prednisolone—ankylosing spondylitis	0.000579	0.00171	CcSEcCtD
Dolasetron—Dermatitis—Prednisolone—ankylosing spondylitis	0.000579	0.00171	CcSEcCtD
Dolasetron—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000577	0.00171	CcSEcCtD
Dolasetron—Fatigue—Prednisone—ankylosing spondylitis	0.000576	0.0017	CcSEcCtD
Dolasetron—Headache—Prednisolone—ankylosing spondylitis	0.000575	0.0017	CcSEcCtD
Dolasetron—Discomfort—Methotrexate—ankylosing spondylitis	0.000575	0.0017	CcSEcCtD
Dolasetron—Constipation—Prednisone—ankylosing spondylitis	0.000571	0.00169	CcSEcCtD
Dolasetron—Confusional state—Methotrexate—ankylosing spondylitis	0.000563	0.00166	CcSEcCtD
Dolasetron—Dizziness—Triamcinolone—ankylosing spondylitis	0.000559	0.00165	CcSEcCtD
Dolasetron—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000558	0.00165	CcSEcCtD
Dolasetron—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000557	0.00165	CcSEcCtD
Dolasetron—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00055	0.00163	CcSEcCtD
Dolasetron—Asthenia—Dexamethasone—ankylosing spondylitis	0.00055	0.00163	CcSEcCtD
Dolasetron—Asthenia—Betamethasone—ankylosing spondylitis	0.00055	0.00163	CcSEcCtD
Dolasetron—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000546	0.00162	CcSEcCtD
Dolasetron—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000546	0.00161	CcSEcCtD
Dolasetron—Pruritus—Dexamethasone—ankylosing spondylitis	0.000542	0.0016	CcSEcCtD
Dolasetron—Pruritus—Betamethasone—ankylosing spondylitis	0.000542	0.0016	CcSEcCtD
Dolasetron—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000539	0.0016	CcSEcCtD
Dolasetron—Rash—Triamcinolone—ankylosing spondylitis	0.000533	0.00158	CcSEcCtD
Dolasetron—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000532	0.00157	CcSEcCtD
Dolasetron—Anorexia—Methotrexate—ankylosing spondylitis	0.000532	0.00157	CcSEcCtD
Dolasetron—Rash—Methylprednisolone—ankylosing spondylitis	0.000531	0.00157	CcSEcCtD
Dolasetron—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000531	0.00157	CcSEcCtD
Dolasetron—Urticaria—Prednisone—ankylosing spondylitis	0.00053	0.00157	CcSEcCtD
Dolasetron—Headache—Triamcinolone—ankylosing spondylitis	0.000529	0.00157	CcSEcCtD
Dolasetron—Headache—Methylprednisolone—ankylosing spondylitis	0.000528	0.00156	CcSEcCtD
Dolasetron—Body temperature increased—Prednisone—ankylosing spondylitis	0.000528	0.00156	CcSEcCtD
Dolasetron—Abdominal pain—Prednisone—ankylosing spondylitis	0.000528	0.00156	CcSEcCtD
Dolasetron—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000524	0.00155	CcSEcCtD
Dolasetron—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000524	0.00155	CcSEcCtD
Dolasetron—Hypotension—Methotrexate—ankylosing spondylitis	0.000521	0.00154	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000508	0.0015	CcSEcCtD
Dolasetron—Dizziness—Betamethasone—ankylosing spondylitis	0.000507	0.0015	CcSEcCtD
Dolasetron—Dizziness—Dexamethasone—ankylosing spondylitis	0.000507	0.0015	CcSEcCtD
Dolasetron—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000501	0.00148	CcSEcCtD
Dolasetron—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000497	0.00147	CcSEcCtD
Dolasetron—Somnolence—Methotrexate—ankylosing spondylitis	0.000496	0.00147	CcSEcCtD
Dolasetron—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000492	0.00146	CcSEcCtD
Dolasetron—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000491	0.00145	CcSEcCtD
Dolasetron—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000485	0.00143	CcSEcCtD
Dolasetron—Rash—Dexamethasone—ankylosing spondylitis	0.000483	0.00143	CcSEcCtD
Dolasetron—Rash—Betamethasone—ankylosing spondylitis	0.000483	0.00143	CcSEcCtD
Dolasetron—Dermatitis—Betamethasone—ankylosing spondylitis	0.000483	0.00143	CcSEcCtD
Dolasetron—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000483	0.00143	CcSEcCtD
Dolasetron—Fatigue—Methotrexate—ankylosing spondylitis	0.000481	0.00142	CcSEcCtD
Dolasetron—Headache—Betamethasone—ankylosing spondylitis	0.00048	0.00142	CcSEcCtD
Dolasetron—Headache—Dexamethasone—ankylosing spondylitis	0.00048	0.00142	CcSEcCtD
Dolasetron—Asthenia—Prednisone—ankylosing spondylitis	0.000479	0.00142	CcSEcCtD
Dolasetron—Pain—Methotrexate—ankylosing spondylitis	0.000477	0.00141	CcSEcCtD
Dolasetron—Pruritus—Prednisone—ankylosing spondylitis	0.000472	0.0014	CcSEcCtD
Dolasetron—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00046	0.00136	CcSEcCtD
Dolasetron—Diarrhoea—Prednisone—ankylosing spondylitis	0.000457	0.00135	CcSEcCtD
Dolasetron—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000456	0.00135	CcSEcCtD
Dolasetron—Urticaria—Methotrexate—ankylosing spondylitis	0.000443	0.00131	CcSEcCtD
Dolasetron—Dizziness—Prednisone—ankylosing spondylitis	0.000441	0.00131	CcSEcCtD
Dolasetron—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000441	0.0013	CcSEcCtD
Dolasetron—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000441	0.0013	CcSEcCtD
Dolasetron—Rash—Prednisone—ankylosing spondylitis	0.000421	0.00125	CcSEcCtD
Dolasetron—Dermatitis—Prednisone—ankylosing spondylitis	0.000421	0.00124	CcSEcCtD
Dolasetron—Headache—Prednisone—ankylosing spondylitis	0.000418	0.00124	CcSEcCtD
Dolasetron—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000411	0.00122	CcSEcCtD
Dolasetron—Asthenia—Methotrexate—ankylosing spondylitis	0.0004	0.00118	CcSEcCtD
Dolasetron—Pruritus—Methotrexate—ankylosing spondylitis	0.000395	0.00117	CcSEcCtD
Dolasetron—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000382	0.00113	CcSEcCtD
Dolasetron—Dizziness—Methotrexate—ankylosing spondylitis	0.000369	0.00109	CcSEcCtD
Dolasetron—Rash—Methotrexate—ankylosing spondylitis	0.000352	0.00104	CcSEcCtD
Dolasetron—Dermatitis—Methotrexate—ankylosing spondylitis	0.000351	0.00104	CcSEcCtD
Dolasetron—Headache—Methotrexate—ankylosing spondylitis	0.000349	0.00103	CcSEcCtD
